Microalbumin Status in Relation to Glycated Haemoglobin and Duration of Type 2 Diabetes Mellitus

Authors

  • Kumananda Acharya Department of Biochemistry, Maharajgunj Medical Campus, IOM, TU, Kathmandu
  • Sangita Regmi Manmohan Cardiothoracic Vascular & Transplant Center, Institute of Medicine, TU, Maharajgunj, Kathmandu
  • Alina Shri Sapkota Department of Biochemistry, Maharajgunj Medical Campus, IOM, TU, Kathmandu
  • Mithileshwer Raut Department of Biochemistry, Maharajgunj Medical Campus, IOM, TU, Kathmandu
  • Bharat Jha Department of Biochemistry, Maharajgunj Medical Campus, IOM, TU, Kathmandu,

DOI:

https://doi.org/10.3126/acclm.v1i1.12310

Keywords:

Diabetes mellitus, Microalbuminuria, HbA1c

Abstract

BACKGROUND: Diabetes mellitus (DM) is one of  the most common endocrine disorders, characterized by hyperglycemia. Diabetic nephropathy is a consequence of long- standing diabetes and urinary microalbumin (Uma) status predicts progression to diabetic nephropathy. This study was conducted to know the status of Uma in relation to duration of diabetes and HbA1c level in patients with Type 2 diabetes mellitus (T2DM).

METHODS: This prospective cross-sectional descriptive study was conducted from July 1, 2014 to January 15, 2015 at TUTH, Kathmandu. Ninety-six known T2DM patients with age 35– 83 years were included in the study. EDTA venous blood and spot urine sample were collected for analysis of HbA1c and Uma respectively. Only those patients having HbA1c concentration ≥ 6.3% and duration of diabetes ≥ 6 months were included under the study.

RESULTS: Overall prevalence of microalbuminuria (MAU) was 39.6 %. MAU had a highly significant correlation with duration of diabetes (r =0.471, p<0.05). Present study has shown positive correlation of MAU with HbA1c level, although statistically insignificant (r=0.245, p>0.05).

CONCLUSIONS: Prolonged exposure to hyperglycemia-induced advanced glycosylation end products accumulations contributes for the development of MAU. So, duration of diabetes mellitus is main contributing factor for the development of MAU rather than HbA1c level alone. Screening for MAU to prevent renal impairment and measuring HbA1c level on a regular basis for good glycemic control are important in diabetic patients.

DOI: http://dx.doi.org/10.3126/acclm.v1i1.12310

Ann. Clin. Chem. & Lab. Med. 1(1) 2015: 21-24

Downloads

Download data is not yet available.
Abstract
1041
PDF
1057

Downloads

Published

2015-03-19

How to Cite

Acharya, K., Regmi, S., Sapkota, A. S., Raut, M., & Jha, B. (2015). Microalbumin Status in Relation to Glycated Haemoglobin and Duration of Type 2 Diabetes Mellitus. Annals of Clinical Chemistry and Laboratory Medicine, 1(1), 21–24. https://doi.org/10.3126/acclm.v1i1.12310

Issue

Vol. 1 No. 1 (2015)

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

  1. The author transfers copyright to the Nepalese Association for Clinical Chemistry.
  2. The journal publishes the work under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal and under the same share-alike license used here.
  3. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).